November 30, 2020
  • November 30, 2020
  • Home
  • Metro News
  • NAFDAC blacklists Indian firm Mars Remedies for illegal drug production
NAFDAC

NAFDAC blacklists Indian firm Mars Remedies for illegal drug production

By on October 26, 2020 0 118 Views

The National Agency for Food and Drug Administration and Control (NAFDAC) has blacklisted an Indian company Mars Remedies PVT Limited for allegedly manufacturing falsified drugs for a pharmaceutical company located in Lagos.

The agency said the company illegally manufactured variations of ciprofloxacin tablets, instead of the approved formulation for export to Nigeria.

In a statement, the Director-General of NAFDAC, Moji Adeyeye said the organisation had banned the importation of all drugs manufactured by the Indian company.

“NAFDAC has blacklisted Mars Remedies PVT Limited, India, for the manufacture of falsified ciprofloxacin Tablets BP 500mg (NAFDAC REG. NO C4-0498) for Pinnacle Health Pharmaceutical Ltd, Surulere, Lagos.

“In view of the unprofessional practice, all products manufactured by Mars Remedies PVT LTD will not be allowed into Nigeria with immediate effect,” NAFDAC said in the statement.

READ ALSO: South Africa may tax the rich as option to bail country out of recession

In a letter to the company on October 9, 2020, addressed to the Managing Director of Mars Remedies PVT Limited, NAFDAC reiterated its position of zero tolerance for substandard and falsified medicines preponderance in Nigeria.

Adeyeye said in the letter entitled, ‘Notice of blacklisting as a manufacturer of substandard and falsified medicines’ the blacklist was “in fulfillment of the regulatory obligation of safeguarding the health of the nation.”

Adeyeye added that the variation in the formulation of the ciprofloxacin 500mg tablets, which may impact on the quality and shelf-life, was not approved by NAFDAC before the changes were made.

Want more Updates? Join 200+ subscribers on our mailing list!

Leave a comment

Your email address will not be published. Required fields are marked *